This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Semler Scientific Framtida tillväxt
Future kriterier kontrolleras 0/6
Semler Scientifics intäkter och resultat förväntas minska med 5.7% och 187.8% per år respektive medan EPS förväntas minska med 195.4% per år.
Viktig information
-187.8%
Tillväxttakt i vinsten
-195.44%
Tillväxttakt för EPS
| Medical Equipment vinsttillväxt | 17.1% |
| Intäkternas tillväxttakt | -5.7% |
| Framtida avkastning på eget kapital | n/a |
| Bevakning av analytiker | Low |
| Senast uppdaterad | 16 Jan 2026 |
Senaste uppdateringarna om framtida tillväxt
Recent updates
Uppdatering av berättelse • Jan 25
SMLR: All Stock Strive Deal Will Unlock Bitcoin Treasury Upside
Analysts have reaffirmed their fair value estimate for Semler Scientific at US$86.00, highlighting adjusted assumptions around the discount rate, revenue trends and profit margin, along with a lower but still very large future P/E expectation as the key drivers behind holding the target steady. What's in the News Strive, Inc.
Uppdatering av berättelse • Jan 08
SMLR: Future Profits And January Meeting Will Support Bullish Thesis
Analysts have reduced their price target on Semler Scientific from US$60.00 to US$51.00, citing softer revenue growth assumptions, a higher discount rate, and a very large future P/E multiple, even as projected profit margins edge slightly higher. What's in the News Semler Scientific has scheduled a special or extraordinary shareholders meeting for January 13, 2026, giving investors a date to watch for company level decisions or approvals that require shareholder input (Key Developments).Uppdatering av berättelse • Dec 18
SMLR: All Stock Acquisition Will Unlock Bitcoin Treasury Upside
Analysts have reduced their price target on Semler Scientific to $86 from $101, citing lower revenue and margin forecasts, as well as uncertainty and opportunity created by the recent all stock acquisition agreement and legal settlement. Analyst Commentary Bullish analysts acknowledge the reduced price targets but continue to frame the all stock acquisition and legal settlement as catalysts that could unlock value for Semler Scientific over the medium term.
Uppdatering av berättelse • Dec 04
SMLR: Shares Will Rise As All Stock Acquisition Drives Bitcoin Treasury Consolidation
Analysts have trimmed their average price target for Semler Scientific by about $15 to roughly $83 per share, citing reduced revenue expectations following updated management guidance and the implications of the recent DOJ settlement. They continue to view the stock as an attractive opportunity in light of the pending all stock acquisition by Strive and consolidation prospects in the corporate bitcoin treasury space.Uppdatering av berättelse • Nov 20
SMLR: Shares Will Reflect Upside As $1.4 Billion Acquisition Advances
Analysts have lowered their fair value estimate for Semler Scientific by approximately $10. This change is due to reduced revenue growth projections and updated guidance in light of recent acquisition and settlement developments.Uppdatering av berättelse • Sep 24
Cardiac And Digital Health Expansion Will Encounter Bitcoin Risks
Analysts have lowered their price target for Semler Scientific from $85.33 to $75.33, citing reduced revenue forecasts following cautious management guidance, weighing of recent legal settlements, and uncertainty around the company’s pivot to a bitcoin treasury strategy despite some bullish views on its potential long-term re-rating. Analyst Commentary Bullish analysts see the acquisition by Strive (ASST) as triggering potential consolidation in the corporate bitcoin treasury sector, presenting a timely opportunity despite market uncertainty around the transaction’s longer-term implications.Analysartikel • Aug 21
Is Semler Scientific (NASDAQ:SMLR) Using Too Much Debt?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Ny berättelse • Aug 10
Cardiac And Digital Health Expansion Will Encounter Bitcoin Risks
Diversification into cardiac disease markets and value-based care tools positions the company for higher recurring revenues and improved long-term margins.Analysartikel • Jul 09
Semler Scientific, Inc.'s (NASDAQ:SMLR) 26% Share Price Surge Not Quite Adding Up
Semler Scientific, Inc. ( NASDAQ:SMLR ) shares have had a really impressive month, gaining 26% after a shaky period...Seeking Alpha • May 29
Semler Scientific: Not The Ideal Bitcoin Treasury Company
Summary Semler Scientific's pivot to a Bitcoin treasury strategy has been successful. However, competition in the Bitcoin Treasury company space is heating up, including many well funded competitors. Declining revenues and free cash flow in its healthcare business are concerning, and Bitcoin is materially outperforming the Company year to date. Read the full article on Seeking AlphaAnalysartikel • May 17
Semler Scientific, Inc.'s (NASDAQ:SMLR) 32% Price Boost Is Out Of Tune With Revenues
Semler Scientific, Inc. ( NASDAQ:SMLR ) shareholders are no doubt pleased to see that the share price has bounced 32...Analysartikel • Mar 25
Here's Why We Think Semler Scientific (NASDAQ:SMLR) Might Deserve Your Attention Today
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Analysartikel • Mar 07
Semler Scientific's (NASDAQ:SMLR) Profits May Not Reveal Underlying Issues
The recent earnings posted by Semler Scientific, Inc. ( NASDAQ:SMLR ) were solid, but the stock didn't move as much as...Analysartikel • Mar 04
Semler Scientific, Inc. (NASDAQ:SMLR) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Unfortunately for some shareholders, the Semler Scientific, Inc. ( NASDAQ:SMLR ) share price has dived 25% in the last...Analysartikel • Jan 15
Semler Scientific, Inc. (NASDAQ:SMLR) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely
Semler Scientific, Inc. ( NASDAQ:SMLR ) shares have retraced a considerable 26% in the last month, reversing a fair...Prognoser för vinst- och omsättningstillväxt
| Datum | Intäkter | Intäkter | Fritt kassaflöde | Kassaflöde från rörelsen | Genomsnittligt Antal analytiker |
|---|---|---|---|---|---|
| 12/31/2026 | 34 | -3 | -3 | -3 | 2 |
| 12/31/2025 | 34 | 5 | -1 | -1 | 2 |
| 9/30/2025 | 37 | 48 | -27 | -27 | N/A |
| 6/30/2025 | 43 | 37 | 12 | 12 | N/A |
| 3/31/2025 | 49 | -30 | 17 | 17 | N/A |
| 12/31/2024 | 56 | 41 | 24 | 24 | N/A |
| 9/30/2024 | 59 | 16 | 22 | 21 | N/A |
| 6/30/2024 | 62 | 16 | 20 | 20 | N/A |
| 3/31/2024 | 66 | 22 | 26 | 26 | N/A |
| 12/31/2023 | 68 | 21 | 21 | 21 | N/A |
| 9/30/2023 | 67 | 20 | 17 | 19 | N/A |
| 6/30/2023 | 65 | 18 | 20 | 22 | N/A |
| 3/31/2023 | 61 | 16 | 14 | 17 | N/A |
| 12/31/2022 | 57 | 14 | 15 | 17 | N/A |
| 9/30/2022 | 54 | 13 | 16 | 17 | N/A |
| 6/30/2022 | 54 | 13 | 16 | 17 | N/A |
| 3/31/2022 | 54 | 16 | 12 | 13 | N/A |
| 12/31/2021 | 53 | 17 | 15 | 16 | N/A |
| 9/30/2021 | 54 | 21 | 19 | 20 | N/A |
| 6/30/2021 | 50 | 22 | 15 | 16 | N/A |
| 3/31/2021 | 42 | 16 | 15 | 16 | N/A |
| 12/31/2020 | 39 | 14 | 14 | 15 | N/A |
| 9/30/2020 | 36 | 11 | 12 | 13 | N/A |
| 6/30/2020 | 34 | 14 | 13 | 14 | N/A |
| 3/31/2020 | 35 | 16 | 13 | 15 | N/A |
| 12/31/2019 | 33 | 15 | 11 | 13 | N/A |
| 9/30/2019 | 30 | 14 | 10 | 11 | N/A |
| 6/30/2019 | 26 | 7 | N/A | 8 | N/A |
| 3/31/2019 | 24 | 6 | N/A | 7 | N/A |
| 12/31/2018 | 21 | 5 | N/A | 5 | N/A |
| 9/30/2018 | 20 | 4 | N/A | 3 | N/A |
| 6/30/2018 | 18 | 2 | N/A | 2 | N/A |
| 3/31/2018 | 15 | 0 | N/A | 1 | N/A |
| 12/31/2017 | 12 | -2 | N/A | 1 | N/A |
| 9/30/2017 | 11 | -2 | N/A | 0 | N/A |
| 6/30/2017 | 9 | -2 | N/A | 0 | N/A |
| 3/31/2017 | 8 | -2 | N/A | -1 | N/A |
| 12/31/2016 | 7 | -3 | N/A | -2 | N/A |
| 9/30/2016 | 8 | -7 | N/A | -4 | N/A |
| 6/30/2016 | 7 | -8 | N/A | -3 | N/A |
| 3/31/2016 | 7 | -8 | N/A | -4 | N/A |
| 12/31/2015 | 7 | -9 | N/A | -4 | N/A |
| 9/30/2015 | 5 | -5 | N/A | -4 | N/A |
| 6/30/2015 | 4 | -5 | N/A | -4 | N/A |
| 3/31/2015 | 4 | -5 | N/A | -4 | N/A |
Analytiker Framtid Tillväxt Prognoser
Intäkter kontra sparande: SMLR s intäkter förväntas minska under de kommande 3 åren ( -187.8% per år).
Resultat vs marknad: SMLR s intäkter förväntas minska under de kommande 3 åren ( -187.8% per år).
Höga tillväxtresultat: SMLR s intäkter förväntas minska under de kommande 3 åren.
Intäkt vs marknad: SMLR s intäkter förväntas minska under de kommande 3 åren ( -5.7% per år).
Hög tillväxtintäkter: SMLR s intäkter förväntas minska under de kommande 3 åren ( -5.7% per år).
Tillväxtprognoser för vinst per aktie
Framtida avkastning på eget kapital
Framtida ROE: Otillräcklig data för att avgöra om SMLR s avkastning på eget kapital förväntas bli hög om tre år
Upptäck tillväxtföretag
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/01/20 21:20 |
| Aktiekurs vid dagens slut | 2026/01/15 00:00 |
| Intäkter | 2025/09/30 |
| Årlig intjäning | 2024/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som används för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och handledningar på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
Semler Scientific, Inc. bevakas av 3 analytiker. 2 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Mark Palmer | Benchmark Company |
| Marc Wiesenberger | B. Riley Securities, Inc. |
| Brett Knoblauch | Cantor Fitzgerald & Co. |